Boston, MA 的 化膿性汗腺炎 臨床試驗
9 項針對 化膿性汗腺炎 的研究正在 Boston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
招募中2 期
- Beth Israel Deaconess Medical Center - Boston- Site Number : 8400001, Boston
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
招募中1 期
- Clinical Site 3, Boston
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
招募中1 期
- Up0122 104, Boston
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
招募中3 期
- Investigative Site US030, Boston
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
招募中2 期
- Boston Childrens Hospital, Boston
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
招募中2 期
- Beth Israel Deaconess Medical Center, Boston
The Safety and Efficacy of Roflumilast Foam in HS
招募中2 期
- Beth Israel Deaconess Medical Center, Boston
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
招募中觀察性研究
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
招募中2 期
- Beth Israel Deaconess Medical Center, Boston
其他城市的 化膿性汗腺炎 試驗
- Tampa, FL7 項研究
- Miami, FL6 項研究
- New York City, NY5 項研究
- Birmingham, AL5 項研究
- Dallas, TX5 項研究
- Phoenix, AZ5 項研究
- New Orleans, LA4 項研究
- Santa Clarita, CA4 項研究
- Scottsdale, AZ4 項研究
- Durham, NC4 項研究
- Minneapolis, MN4 項研究
- Philadelphia, PA4 項研究
Boston 的其他研究
- 乳癌112 項研究
- 非小細胞肺癌90 項研究
- 癌症（所有類型）85 項研究
- 轉移性癌症63 項研究
- 大腸直腸癌63 項研究
- 肺癌62 項研究
- 卵巢癌61 項研究
- 前列腺癌59 項研究
- 憂鬱症52 項研究
- 子宮內膜癌50 項研究
- 心臟衰竭44 項研究
- 急性髓系白血病44 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。